Treatment > Chemotherapy
RAD-001
Basic Description:
Everolimus - Afinitor (RAD-001) - Newest Open Trial
"Everolimus, Afinitor (RAD-001), is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR (mammalian target of rapamycin) inhibitor."
|
Common Side Effects:
- Lung and Breathing Problems
- Infections
- Kidney Failure
- Mouth Ulcers
- Liver problems
- Vaccinations - patients should not have live vaccinations while on Afinitor
- Contraindicated with certain medications and certain foods
Additional Possible Side Effects:
- Mouth Ulcers
- Feeling Weak
- Cough
- Shortness of Breath
- Diarrhea
- Rash, Dry Skin, Itching
- Nausea and Vomiting
- Fever
- Loss of Appetite
- Swelling - Arms, Legs, Feet or Ankles
- Infections - Respiratory Tract, Sinuses and Ears
- Constipation
- Stomach pain
- Seizure
- Headache
- Dizziness
- Stuffy / Runny Nose
- change in personality
- Low White Cell Count
- High Fat Content in Blood
NF2 NYC Support Group, New York
Email: Lori Davila at lori@nf2nycsupport.org
Copyright © 2008 - 2012
DISCLAIMER: www.nf2nycsupport.org is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. While we hope the information found on the www.nf2nycsupport.org site is helpful in offering suggestions in topics to discuss with your doctor, information found here should not be considered actual medical advice. Medical advice should always be sought by consultation with a medical professional.